Exciting Opportunity for Life Science Startups
Up to $500,000 in funding is now available to support minority- and women-led life science startups focusing on novel drug development. Cure, a healthcare innovation campus, has partnered with Deerfield Management Company to offer the XSeed Award for the year 2025.
The Purpose of the XSeed Award
The XSeed Award aims to empower innovative startups by providing substantial funding, specifically up to $250,000 for two selected teams. This initiative is specifically geared toward life science and healthcare startups based in New York City, nurturing their potential to develop transformative therapies.
Commitment to Innovation
James E. Flynn, Managing Partner at Deerfield and founder of Cure, highlighted the program's importance, saying, "The XSeed Award underscores our commitment to fostering innovation and collaboration in New York City's healthcare ecosystem." By focusing on minority- and women-led startups, the award seeks to create a more inclusive environment while accelerating therapy development.
History and Growth of the Award
Initiated in 2020 by Deerfield Management and the New York City Economic Development Corporation (NYCEDC), the XSeed Award responds to critical funding gaps experienced by a diverse population of talented researchers and entrepreneurs. This program is a prime example of Deerfield's dedication to promoting inclusivity within the life sciences sector.
Mentorship Opportunities
The winning teams will not only receive funding but will also benefit from the extensive Cure ecosystem. They will gain access to mentoring designed to facilitate the transition of promising research to the marketplace. This comprehensive support will help enhance their networks and visibility within the healthcare landscape in New York City.
The Application Process
Applications for the 2025 XSeed Award are open until February 28, 2025, and presentations will be held for virtual finalists on April 17, 2025. Winners will be celebrated during a ceremony hosted by Cure in May 2025, marking a significant step towards nurturing groundbreaking innovations.
Leadership Committee and Finalists
The XSeed Award finalists will present their projects to a distinguished panel, including notable figures from the healthcare and life sciences community. This leadership committee includes experts like Joseph Pearlberg, MD, PhD, and Claire Pomeroy, MD, showcasing a robust network supporting the growth of these startups.
Why Diversity Matters
Cecilia Kushner, Chief Strategy Officer at NYCEDC, emphasized that by empowering minority- and women-led startups, they are addressing both funding gaps and diversifying leadership in healthcare innovation. This intent is to ensure that a wide range of solutions emerges from various perspectives, benefiting the healthcare system as a whole.
About Deerfield Management
Deerfield Management is an investment management firm devoted to advancing healthcare through strategic investments, information sharing, and philanthropy. The firm strives to connect people, capital, ideas, and technology, creating collaborative opportunities across the healthcare ecosystem.
About Cure
Cure is a prominent healthcare innovation campus equipped with state-of-the-art laboratories and collaborative workspaces. It supports startups and established companies, encouraging synergies and partnerships across the healthcare sector. Cure offers invaluable resources, including mentoring and networking, aimed at facilitating advancements in health and healthcare innovation.
Frequently Asked Questions
What is the XSeed Award?
The XSeed Award is a funding initiative designed to support minority- and women-led life science startups focusing on innovative drug development.
Who can apply for the XSeed Award?
Applications are welcome from life science and healthcare startups that are minority- or women-led and based in New York City.
When is the application deadline?
The deadline for submitting applications for the 2025 XSeed Award is February 28, 2025.
What do winners receive?
The two winning teams will receive up to $250,000 each, along with mentorship and networking opportunities to advance their research and visibility.
Why is diversity important in healthcare innovation?
Diversity in healthcare innovation ensures a broader range of solutions emerges, addressing various health challenges more effectively and inclusively.
